Shun Fang

995 citations
22 papers · 781 indexed · h-index 13
Topics
Lung Cancer Research Studies (7 papers)RNA modifications and cancer (6 papers)Cancer-related molecular mechanisms research (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Shun Fang

22 papers receiving 776 citations

Peers

Shun Fang
Comparison fields: 5 of 80
  • Molecular Biology 648
  • Cancer Research 492
  • Oncology 113
  • Epidemiology 57
  • Pulmonary and Respiratory Medicine 35
Replace Kristin Wächter with:
Kristin Wächter Germany
Ting Sun China
Qiang Qin China
Radu Pîrlog Romania
Min Guo China
Song-Mei Liu China
Hung-Jung Wang Taiwan
Zhicheng Pan China
Elena M. Tchevkina Russia
Shun Fang relative to Kristin Wächter Germany Kristin Wächter's profile →
Citations per field
00.5×1.5×1.9×
Kristin Wächter · 1×
Citations per year

Countries citing papers authored by Shun Fang

Since Specialization
Citations

This map shows the geographic impact of Shun Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Fang more than expected).

Fields of papers citing papers by Shun Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Fang. The network helps show where Shun Fang may publish in the future.

Co-authorship network of co-authors of Shun Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Fang. A scholar is included among the top collaborators of Shun Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Fang. Shun Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 5
3 2
4 31
5 97
6 85
7 1
8 18
9
HOTAIR contributes to chemoresistance by activating NF-κB signaling in small-cell lung cancer.
8
10 48
11 194
12 4
13 3
14 20
15
miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX.
22
16 34
17 10
18 97
19 39
20 17

About Shun Fang

Shun Fang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 22 papers that have together received 781 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (492 citations), Molecular Biology (648 citations) and Oncology (113 citations). Shun Fang has collaborated with scholars based in China and United States. Frequent co-authors include Linlang Guo, Man Li, Yuchun Niu, Ting Wei, Weimei Huang, Feng Ma, Ruixiang Tang, Jie Yang, Hong-Yi Gao and Man Li. Their work appears in journals such as Diabetes, British Journal of Cancer and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026